Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Culture, Organoids & Organ-on-a-Chip Europe 2021

Shay Soker's Biography

Shay Soker, Professor of Regenerative Medicine and Chief Science Program Officer, Wake Forest Institute for Regenerative Medicine

Dr. Shay Soker is a Professor of Regenerative Medicine at the Wake Forest Institute for Regenerative medicine and an affiliated Professor of Cancer Biology, Physiology & Pharmacology, Biomedical Engineering and Surgical Sciences. Dr. Soker developed programs in neo-vascularization of bioengineered tissues, including angiogenic gene transfer to enhance tissue vascularization, cell therapy using vascular cells and ex-vivo revascularization of bioengineered tissues and organs. His stem cell research focuses on the identification and isolation of stem cells from different sources, including adult and fetal stem cells from amniotic fluid and placenta, and their directed differentiation to generate tissues in vitro and in vivo. In parallel, Dr. Soker’s group is exploring tissue-derived extracellular matrices as scaffolds for whole organ bioengineering. Recently, Dr. Soker applied 3D tissue engineering and bioprinting technologies to develop small 3D tissue constructs (organoids) for studying tissue development, as human disease models, for drug toxicity testing and drug discovery. Some of Dr. Soker’s projects are now being discussed with industry collaborators in order to create new regenerative medicine product.

Shay Soker Image

Tissue Organoids For Disease Modeling and Therapy Development

Tuesday, 29 June 2021 at 14:30

Add to Calendar ▼2021-06-29 14:30:002021-06-29 15:30:00Europe/LondonTissue Organoids For Disease Modeling and Therapy Development3D-Culture, Organoids and Organ-on-a-Chip Europe 2021 in Rotterdam, The NetherlandsRotterdam, The

3D human tissue organoids replicate native tissue structure and function and can be studied in vitro for several weeks to allow intensive investigations. Besides their advantages in drug toxicity testing and for development of new drugs, the human tissue organoid platform serves as a model system to explore human tissue development and disease. Our recent research was focused on the use of tissue organoids to study human development and congenital diseases as well as other common diseases such as tissue fibrosis and cancer. Once a disease model is established, patient-specific (personalized) therapies can be developed.

Add to Calendar ▼2021-06-28 00:00:002021-06-30 00:00:00Europe/London3D-Culture, Organoids and Organ-on-a-Chip Europe 20213D-Culture, Organoids and Organ-on-a-Chip Europe 2021 in Rotterdam, The NetherlandsRotterdam, The